My Healthcare Reporter
SEE OTHER BRANDS

Your healthcare and wellness news reporter

My Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Healthcare Reporter.

Press releases published on September 8, 2025

Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030

Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030

NASHVILLE, Tenn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the pricing of its private offering (the “Offering”) of $250.0 million aggregate …

Bonita Springs Healthcare Services Enhances Quality of Life for Seniors in Santa Clara

Bonita Springs Healthcare Services Enhances Quality of Life for Seniors in Santa Clara

Bonita Springs Healthcare Services further elevates the assisted living experience with specialized memory care services for those facing cognitive challenges. GILROY, CA, UNITED STATES, September 8, 2025 /⁨EINPresswire.com⁩/ -- Bonita Springs Healthcare …

Bonita Springs Healthcare Services Unveils Premier Senior Care Community in Santa Clara

Bonita Springs Healthcare Services Unveils Premier Senior Care Community in Santa Clara

Continuing its tradition of excellence, Bonita Springs introduces innovative support programs that foster active aging and emotional well-being. GILROY, CA, UNITED STATES, September 8, 2025 /⁨EINPresswire.com⁩/ -- Bonita Springs Healthcare Services, a …

Bonita Springs Healthcare Services Unveils Premier Assisted Living Facility in Santa Clara

Bonita Springs Healthcare Services Unveils Premier Assisted Living Facility in Santa Clara

Safety and personalized attention are at the core of Bonita Springs’ philosophy. Licensed nurses and certified caregivers provide 24/7 support. GILROY, CA, UNITED STATES, September 8, 2025 /⁨EINPresswire.com⁩/ -- Bonita Springs Healthcare Services, a …

Dental Composites Market Size is Estimated to Reach US$ 171.3 Mn and Expanding at a CAGR of 8.6% by 2034 | TMR Research

Dental Composites Market Size is Estimated to Reach US$ 171.3 Mn and Expanding at a CAGR of 8.6% by 2034 | TMR Research

The Global Dental Composites Market 2034: Driving Growth Through Expanding Applications and Rising Demand for Aesthetic Restorations WILMINGTON, DE, UNITED STATES, September 8, 2025 /⁨EINPresswire.com⁩/ -- The global market for dental composites, a …

Spot Check Monitors Market to Cross USD 7.4 Billion by 2034, Rising at 7.3% CAGR from USD 3.5 Billion in 2023 | TMR

Spot Check Monitors Market to Cross USD 7.4 Billion by 2034, Rising at 7.3% CAGR from USD 3.5 Billion in 2023 | TMR

Spot Check Monitors Market to surpass US$ 7.4 Bn by 2034, growing at 7.3% CAGR, driven by home healthcare demand, chronic disease rise, and telehealth adoption. WILMINGTON, DE, UNITED STATES, September 8, 2025 /⁨EINPresswire.com⁩/ -- The spot check …

NYUAD researchers develop 3D-printed capsule to sample gut microbiome

NYUAD researchers develop 3D-printed capsule to sample gut microbiome

CORAL capsule offers non-invasive access to understudied intestinal microbes ABU DHABI, ABU DHABI, UNITED ARAB EMIRATES, September 8, 2025 /⁨EINPresswire.com⁩/ -- Gut microbiome studies have long relied on fecal samples, which primarily represent microbes …

NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness

NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness

TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to …

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)

LOUISVILLE, Ky., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Sanofi for Wayrilz (rilzabrutinib), which has been approved by the U.S. Food and Drug …

Sienna Senior Living Announces the Opening of Its Long-Term Care Community in North Bay and Retirement Community in Brantford, Ontario

Sienna Senior Living Announces the Opening of Its Long-Term Care Community in North Bay and Retirement Community in Brantford, Ontario

MARKHAM, Ontario, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) announced today that it has officially opened its Northern Heights Community, the Company’s first completed long-term care redevelopment …

PharmAla Completes Import of LaNeo MDMA for US Distribution

PharmAla Completes Import of LaNeo MDMA for US Distribution

TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …

Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang

Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang

LOS ANGELES, CA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Immix”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced that …

Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)

Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)

At Week 96 participants experienced even greater reductions in daily cornstarch intake while maintaining low levels of hypoglycemia, improved levels of euglycemia and improved fasting tolerance Phase 3 results are further supported by early data from open- …

Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference

Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference

Wilmington, DE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will now present at the Baird 2025 Global Healthcare Conference at 2:35 p.m. ET on …

Rapport Announces Proposed Public Offering of Common Stock

Rapport Announces Proposed Public Offering of Common Stock

BOSTON and SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

EDEN PRAIRIE, Minn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from …

Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering

Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering

NEW YORK and WALTHAM, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune …

Abivax Presents First Half 2025 Financial Results

Abivax Presents First Half 2025 Financial Results

Abivax Presents First Half 2025 Financial Results PARIS, France, September 8, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing …

Nora Mental Health Opens New Location in Dallas, TX, Bringing Compassionate, Accessible Mental Health Care to the Community

Nora Mental Health Opens New Location in Dallas, TX, Bringing Compassionate, Accessible Mental Health Care to the Community

Dallas, TX , Sept. 08, 2025 (GLOBE NEWSWIRE) -- Nora Mental Health is excited to announce the grand opening of its newest clinic in Dallas, Texas, located at 8140 Walnut Hill Ln, Suite 835. The new location reflects the growing demand for accessible, high- …

Claisen Launches Direct-to-Consumer Personalized Kits for Gastrointestinal Diseases (Heartburn, Bloating, and Gas)

Claisen Launches Direct-to-Consumer Personalized Kits for Gastrointestinal Diseases (Heartburn, Bloating, and Gas)

BOSTON, MA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Claisen Inc., a telemedicine and digital gastrointestinal health company, today announced the launch of personalised, direct-to-consumer gut health kits that help patients manage acid reflux/GERD, bloating, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions